Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Clinical trial NCT04985825 · WITHDRAWN

Trial details

NCT number: NCT04985825
Sponsor: Pega-One S.A.S.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma

Start date: 2021-12-16
Primary completion: 2022-08-17
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.